Clindamycin Injection, Solution
Product Images NDC 71872-7284

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clindamycin (NDC 71872-7284). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7284-1.pdp (71872 7284 1)

Clindamycin Injection, USP 150 mg/mL solution in a 6 mL single-dose vial, labeled as 900 mg total per vial. The label specifies use for intramuscular or intravenous administration, with instructions to dilute before intravenous use. Manufacturer listed as Sagent Pharmaceuticals and repackaged by Medical Purchasing Solutions, LLC.*

FDA Label Image

Structural Formula (Cli04 0016 01)

Chemical structure diagram of clindamycin phosphate, the active ingredient in Clindamycin injection solution. The image shows the molecular arrangement of carbon, hydrogen, oxygen, nitrogen, sulfur, and phosphorus atoms that constitute clindamycin phosphate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.